BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11316199)

  • 1. Exacerbation of inflammatory bowel disease associated with use of celecoxib.
    Bonner GF
    Am J Gastroenterol; 2001 Apr; 96(4):1306-8. PubMed ID: 11316199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lower gastrointestinal hemorrhage associated with celecoxib].
    Serrano Pozo A; Jara Palomares L; Fuentes Rodríguez F; Calderón Sandubete E
    An Med Interna; 2003 Sep; 20(9):497. PubMed ID: 14755912
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):157-9. PubMed ID: 16469674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperkalemia and celecoxib].
    Rego MJ; Fonseré N; Martí S; Rey-Joly C
    Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
    [No Abstract]   [Full Text] [Related]  

  • 5. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
    Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Aisenberg J; Bhadra P; Berger MF
    Aliment Pharmacol Ther; 2007 May; 25(10):1211-22. PubMed ID: 17451567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotic syndrome associated to celecoxib].
    Sirvent AE; Enríquez R; Amorós F; Reyes A
    Nefrologia; 2005; 25(1):81-2. PubMed ID: 15789542
    [No Abstract]   [Full Text] [Related]  

  • 7. Celecoxib (Celebrex): 1 year later.
    McMorran M; Morawiecka I
    CMAJ; 2000 Apr; 162(7):1044-6, 1048-50. PubMed ID: 10763409
    [No Abstract]   [Full Text] [Related]  

  • 8. Celecoxib-induced photoallergic drug eruption.
    Yazici AC; Baz K; Ikizoglu G; Kokturk A; Uzumlu H; Tataroglu C
    Int J Dermatol; 2004 Jun; 43(6):459-61. PubMed ID: 15186233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic vasculitis associated with celecoxib.
    Jordan KM; Edwards CJ; Arden NK
    Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
    [No Abstract]   [Full Text] [Related]  

  • 10. Aseptic meningitis possibly associated with celecoxib.
    Papaioannides DH; Korantzopoulos PG; Giotis CH
    Ann Pharmacother; 2004 Jan; 38(1):172. PubMed ID: 14742817
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous reaction to oral celecoxib with positive patch test.
    Alonso JC; Ortega JD; Gonzalo MJ
    Contact Dermatitis; 2004 Jan; 50(1):48-9. PubMed ID: 15059110
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaphylactic shock induced by celecoxib].
    Habki R; Vermeulen C; Bachmeyer C; Charoud A; Mofredj A
    Ann Med Interne (Paris); 2001 Sep; 152(5):355. PubMed ID: 11593149
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 18. Celecoxib and CVS risk--lessons from the APC and PreSAP studies.
    Armstrong DJ
    Rheumatology (Oxford); 2007 Apr; 46(4):561-2. PubMed ID: 17132690
    [No Abstract]   [Full Text] [Related]  

  • 19. Erectile dysfunction induced probably by celecoxib.
    Dhikav V; Gupta S; Anand KS
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):211-2. PubMed ID: 18236511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Celecoxib].
    Babić-Naglić D
    Reumatizam; 2001; 48(2):27-8. PubMed ID: 12476745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.